Comparison

ONCOassist vs EHA2024

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

ONCOassist

This medical decision-support tool is designed for oncology professionals. It offers a comprehensive suite of resources, including treatment protocols, adjuvant calculators, drug information, and toxicity grading, to aid in effective patient care and decision-making.

Highlights
  • NCCN Treatment Protocols
  • Adjuvant Survival Rate Calculators
  • Medical Formula Calculators
  • CTCAE Toxicity Grading
  • AJCC TNM Staging
  • Oncology Drug Information
  • Drug Interaction Checker
Features
Read full description

Please note: This application, as a decision-support aid, is to be used  by a practicing healthcare professional(“HCP”) and does not replace clinical judgement. It is not designed for use by patients and does not replace the advice of a doctor. ONCOassist is a comprehensive suite of decision support tools developed by oncology professionals, for oncology professionals. It includes a range of breakthrough tools designed to manage patient care effectively. Let's take a closer look at some of the features available: • NCCN Treatment Protocols: Developed in collaboration with the NCCN, this tool provides information on regimens taken from the NCCN template database. • Adjuvant Tools: These tools offer 5 and 10-year overall survival rates for patients with and without chemotherapy in an adjuvant setting. Breast cancer, colon cancer, and GIST tools are among the many adjuvant decision support tools available. • Useful formulas: Body Surface Area, Chemotherapy Dose Calculator, QTc, ECOG Performance Score, Khorana Score, MASCC Risk Index, and many more are included. These calculators simplify medical calculations and include frequently needed conversions and dosage calculations. • Common Toxicity Criteria for Adverse Events (CTCAE v4.0 & 5.0): This tool provides a standardized classification of adverse effects of drugs used in cancer therapy. CTCAE versions 5.0 and 4.0 are available in an easy-to-use and interactive format. • AJCC TNM staging: The tool provides criteria for every malignancy and includes the AJCC 7th, 8th, and 9th edition staging criteria. • Prognostic Scores: This tool offers over 17 prognostic scores for a range of specialties. It helps with prognostication, risk stratification, and determining eligibility for specific treatments or clinical trials. • Drug info section: Over 200 oncology drugs are available in an easy-to-use and interactive format. • Drug interaction checker: This tool helps users quickly check for potential drug interactions. • IO toxicity management tool: This tool is designed to manage immune-related adverse events. • ONCOnews: From breaking news to in-depth analysis, ONCOnews brings together all oncology news sources in one place. • ONCOvideos: This offers access to the most recent videos from Oncology Spotlight, which provides insights into the experiences of oncology professionals. Additionally, users can watch OncoAlert and Oncology Brother videos. ONCOassist offers oncology professionals the following benefits: Saves Time Oncology professionals no longer waste time searching through the internet for safe validated information to aid them with their decision making, all of the tools and information they need is available within ONCOassist and is available without the need for internet access. Improves quality of care ONCOassist promotes the use of evidence-based medicine. It is also the only CE approved oncology app on the market. Helps Empower Patients Adjuvant decision support tools contain patient-friendly information to allow for a more collaborative decision-making process. Regularly updating ONCOassist will be updated regularly with new prognostic tools and calculators. We will listen to your feedback and update accordingly. Email us at any time using feedback@oncoassist.com. ONCOassist is regulated by the Irish Health Products Regulatory Authority and is CE marked for conformance as a medical device.

About

EHA2024

This congress mobile app provides access to the European Hematology Association's annual event. It allows attendees to browse the program, save sessions, find locations, access content, and interact via Q&A. It serves as a digital tool for both in-person and virtual participants.

Highlights
  • Browse congress program
  • Save sessions
  • Find locations
  • Access all content
  • Interact via Q&A
  • Live-streamed content access
Features
Read full description

Welcome to the EHA2024 Congress Mobile. The European Hematology Association promotes excellence in patient care, research, and education in hematology. EHA serves medical professionals, researchers, and scientists with an active interest in hematology and is proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology. “Towards prevention, cure, and quality of life for all patients with blood disorders”. The EHA2024 Congress is taking place in-person from June 13-16, 2024 in Madrid and live-streamed. By downloading the Congress Mobile App, you have the Congress in the palm of your hands: browse the program, save sessions of your interest, find your location, access all content, and interact via the Q&A feature. For virtual attendees, the Congress Mobile App is the tool to follow the EHA Congress content from any device. For more information, check https://ehaweb.org/congress/eha2024-hybrid-congress/eha2024-hybrid-congress/

Screenshots

ONCOassist4 screens
EHA20244 screens

Verdict

The call

The clearest difference is rating: ONCOassist at 4.9 against EHA2024's 1.0. ONCOassist also leads on ratings volume (116 vs 1). EHA2024's advantage is ads (none vs shown) and monetization model (free vs ad-supported). On price, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

ONCOassist holds the better App Store score, 4.9 against 1.0. That said, the two scores are not equally well evidenced: ONCOassist has 116 ratings behind it against 1, so its average is the more settled of the two.

Scorecard5 real differences · 5 level
ONCOassist versus EHA2024: the parameters behind the verdict, then further details
ParameterONCOassistEHA2024
PriceFreeFree
Rating4.9 (116 ratings) — better1.0 (1 ratings)
Positive reviews100.0% of reviews—
Number of ratings116 — better1
Update frequencyEvery 10 days—
AdsYesNo — better
In-app purchasesNoNo
MonetizationAd-supportedFree — better
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS15.613.0 — better
Further details — not scored
Size245 MB47 MB
Age rating17+17+
DeveloperPortable Medical Technology LtdJMarquardt Technologies GmbH

Customer experience

ONCOassist

All ratings116 ratings
Positive98.3%
Neutral0.0%
Negative1.7%
Written reviews113 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

EHA2024

All ratings1 ratings
Positive0.0%
Neutral0.0%
Negative100.0%

Bugs and requests

ONCOassist

Requested features

3 requests
  • Radiation oncology topics
  • Option in Spanish
  • Russian language

EHA2024

Not enough reviews yet to summarise bugs or requests.

In-app purchases

None

ONCOassist

No in-app purchases

None

EHA2024

No in-app purchases

Questions

Is ONCOassist free?
ONCOassist is free to download, with no in-app purchases.
Is EHA2024 free?
EHA2024 is free to download, with no in-app purchases.
Which has better reviews, ONCOassist or EHA2024?
ONCOassist is rated higher. ONCOassist averages 4.9 out of 5 from 116 ratings, while EHA2024 averages 1.0 from 1 ratings.
Do ONCOassist or EHA2024 have ads?
ONCOassist shows ads; EHA2024 does not.

Other comparisons